- Corebridge Financial reported an operating EPS of $1.36, surpassing the estimated $1.14.
- The company’s adjusted revenue was $4.42 billion, which fell short of the estimated $4.91 billion.
- Policy fees came in at $721 million, exceeding the estimate of $711.2 million.
- Corebridge incurred a net loss of $660 million, contrary to the projected profit of $608.5 million.
- Adjusted operating income was recorded at $750 million.
- The sentiment among analysts includes 12 buy ratings, 3 hold ratings, and 0 sell ratings.
A look at Corebridge Financial Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 2 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Corebridge Financial, Inc. is positioned well for the long term, as indicated by the Smartkarma Smart Scores. With a strong Value score of 4, the company is deemed to be attractively priced in the market. Additionally, a solid Dividend score of 4 suggests that Corebridge Financial offers stable dividend payouts. However, the Growth score of 2 hints at slower expected growth compared to other factors. Despite this, the company shows Resilience with a score of 3, indicating a steady ability to weather market fluctuations. Furthermore, a Momentum score of 4 showcases positive market sentiment and performance for Corebridge Financial.
Overall, Corebridge Financial, Inc. appears to be a promising investment option for individuals seeking a balance of value, dividend stability, and market momentum. With a focus on retirement solutions and insurance products, Corebridge Financial has a global reach, catering to customers worldwide. Investors may find the company’s blend of strong value, consistent dividends, and positive momentum attractive for long-term investment objectives.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
